Semaglutide is a recombinant DNA produced polypeptide analog of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.
CAT No: 10-101-325
CAS No: 910463-68-2
Synonyms/Alias: Sermaglutide; UNII-53AXN4NNHX; NNC 0113-0217; 53AXN4NNHX
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C187H291N45O59 |
M.W/Mr. | 4113.57 |
Application | The treatment of type 2 diabetes |
Appearance | White to off-white powder |
Purity | ≥ 98% (or refer to the Certificate of Analysis) |
Activity | Agonist |
Target | Glucagon Receptor |
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.